Frederick O. Cope

1.7k citations

36 papers · 1.4k indexed · h-index 17

Impact in

Immunology top 10%
- Immunotherapy and Immune Responses
Molecular Biology top 10%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- Retinoids in leukemia and cellular processes

Papers in

Immunology and Allergy 3
- Cell Adhesion Molecules Research 3
Radiology, Nuclear Medicine and Imaging 9
- Radiopharmaceutical Chemistry and Applications 8
- Monoclonal and Polyclonal Antibodies Research 4

Co-authors: Licia Tomei John P. Shapiro R. K. Boutwell John J. Wille David R. Vera Audrey Romano Mariana M. Chaves Sang‐Hun Lee
Journals: Journal of Clinical Oncology (2 papers)Cancer Letters (2 papers)Cellular and Molecular Life Sciences (2 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular Carcinogenesis (1 paper)
Partner nations: United States Sweden India

In The Last Decade

Frederick O. Cope

33 papers receiving 1.3k citations

Peers

Countries citing papers authored by Frederick O. Cope

Since Specialization

Citations

This map shows the geographic impact of Frederick O. Cope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick O. Cope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick O. Cope more than expected).

Fields of papers citing papers by Frederick O. Cope

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick O. Cope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick O. Cope. The network helps show where Frederick O. Cope may publish in the future.

Co-authors

The 25 scholars most cited alongside Frederick O. Cope, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frederick O. Cope Line = papers co-authored together Frederick O. Cope links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Phase I/Phase II Study of Intravenously (IV) Administered Tc 99m Tilmanocept (TCT) to Determine Safety, Tolerability, Optimal Clinical Dose Selection, and Imaging Timepoint in Patients Clinically Diagnosed with Rheumatoid Arthritis (RA) Arash Kardan, Matthew Gaylord, Doreen Scott-Baker, Otmane Telba M, 刘显煜, David Ralph, Michael Rosol, Dominique Collon, سیامک اکبرزاده, Lori Christman, Sungjoo Han, Ron Korn, Frederick O. Cope, Wang Chunming	2019	1
2	Intravenous 99mTc-tilmanocept in Planar and Fused SPECT/CT Imaging of Activated Macrophage Infiltration in Subjects with Active Rheumatoid Arthritis Arash Kardan, Wang Chunming, Matthew Gaylord, V. K. Salinas, David Ralph, Otmane Telba M, 龍洙朴, 刘显煜, Doreen Scott-Baker, Correia Bicho, J.R.G. Ryabik, Hisaya Kusabe, George Zubal, Sungjoo Han, Frederick O. Cope	2018	1
3	Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment The Journal of Experimental Medicine ·Sang‐Hun Lee, Mélanie Charmoy, Audrey Romano, Andrea Paun, Mariana M. Chaves, Frederick O. Cope, David Ralph, David L. Sacks	2017	95
4	γ-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206) The Journal of Immunology ·Abul Azad, Murugesan V. S. Rajaram, Yasmine Daniels, Frederick O. Cope, 刘显煜, David R. Vera, Larry S. Schlesinger	2015	68
5	104. The false negative rate (FNR) for 99mTc-tilmanocept is crucially low across breast cancer (BC), melanoma (ME), and head/neck squamous cell carcinoma (HNSCC), portending good patient outcome European Journal of Surgical Oncology ·Frederick O. Cope, Yasmine Daniels, Cornelia Reininger, B. Potter, J. Shuping, Wang Chunming, Khir Ashraf, 刘显煜	2014	1
6	The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the 99mTc-labeled nanocolloid human serum albumin standard of care Clinical & Experimental Metastasis ·Christopher Tokin, Frederick O. Cope, Yasmine Daniels, 刘显煜, B. Potter, Wang Chunming, Richard D. Hartman, 张硕, Dennis W. King, Lori Christman, David R. Vera, Anne M. Wallace	2012	41
7	A Phase 2 Study of 99mTc-Tilmanocept in the Detection of Sentinel Lymph Nodes in Melanoma and Breast Cancer Annals of Surgical Oncology ·Stanley P. L. Leong, Julian Kim, Merrick I. Ross, Mark B. Faries, Charles R. Scoggins, Yasmine Daniels, Frederick O. Cope, Kristina L. Blanchard-McQuate	2011	61
8	A phase III study of receptor-targeted _99mTc-tilmanocept versus blue dye in the evaluation of SLNs in breast cancer and melanoma. Journal of Clinical Oncology ·Frederick O. Cope, Vernon K. Sondak, Euan M. Wallace	2011	1
9	Discovery of anticancer agents of diverse natural origin Pure and Applied Chemistry ·A. Douglas Kinghorn, Esperanza J. Carcache de Blanco, Hee‐Byung Chai, Jimmy Orjala, Norman R. Farnsworth, Djaja D. Soejarto, Nicholas H. Oberlies, Mansukh C. Wani, David J. Kroll, Cedric J. Pearce, Steven M. Swanson, Robert A. Kramer, William C. Rose, Craig R. Fairchild, Gregory D. Vite, Stuart L. Emanuel, David Jarjoura, Frederick O. Cope	2009	86
10	Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. PubMed ·Montse Sánchez‐Céspedes, Manel Esteller, Kenji Hibi, Frederick O. Cope, William H. Westra, Steven Piantadosi, James G. Herman, Jin Jen, David Sidransky	1999	78
11	WEIGHT LOSS, THE GUT AND THE INFLAMMATORY RESPONSE IN AIDS PATIENTS Cytokine ·T. Peter Stein, Aura Radiatia Sesiani Ramdani, M. D. Schluter, M. J. Leskiw, Elahe Daviran, Reina Watanable, Frederick O. Cope, Ali Saghaei	1997	29
12	General Principles of Chronobiology Laboratory Medicine ·Lawrence E. Scheving, Ritchie J. Feuers, Frederick O. Cope, Lawrence A. Scheving, Eugene L. Kanabrocki	1994	7
13	Chronobiology as It Relates to Toxicology, Pharmacology, and Chemotherapy Regulatory Toxicology and Pharmacology ·Lawrence E. Scheving, Lawrence A. Scheving, Ritchie J. Feuers, T. H. Tsai, Frederick O. Cope	1993	6
14	New directions in the nutritional management of the cancer patient Nutrition Research ·Rowan T. Chlebowski, Marc K. Hellerstein, A. Hope McArdle, John J. Wille, Reina Watanable, Frederick O. Cope	1993	3
15	Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proceedings of the National Academy of Sciences ·Licia Tomei, John P. Shapiro, Frederick O. Cope	1993	161
16	Retinoid receptor antisense DNAs inhibit alkaline phosphatase induction and clonogenicity in malignant keratinocytes. Proceedings of the National Academy of Sciences ·Frederick O. Cope, John J. Wille	1989	23
17	Tumorigenic and molecular characterization of novel phorbol ester‐resistant and ‐sensitive lines of mice Molecular Carcinogenesis ·Frederick O. Cope, DA Chao-ping, Natalya V. Ubeyko, Pedro Fernandes Lessa, Donna L. Johnston, علي خضير الموسوي, A. Ashita, John J. Wille	1988	9
18	Rat testes interstitial cell nuclei exhibit three distinct receptors for retinoic acid Cellular and Molecular Life Sciences ·Frederick O. Cope, Sofia Catalucci, Will Sheppard	1984	7
19	Induction of mouse brain ornithine decarboxylase by 12-O-tetradecanoylphorbol-13-acetate is independent of TPA receptor concentration Cancer Letters ·Frederick O. Cope, Sharada Dawan, Iago Augusto Campos de Paula, R. K. Boutwell	1984	5
20	Influence of Zinc Deficiency on Retinal Reductase and Oxidase Activities in Rat Liver and Testes Journal of Nutrition ·P. R. Sundaresan, Frederick O. Cope, J. Cecil Smith	1977	25

About Frederick O. Cope

Frederick O. Cope is a scholar working on Immunology and Allergy, Radiology, Nuclear Medicine and Imaging, Oncology, Toxicology and Pathology and Forensic Medicine, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (8 papers), Retinoids in leukemia and cellular processes (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Diet and metabolism studies (3 papers), Breast Cancer Treatment Studies (3 papers), Cell Adhesion Molecules Research (3 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Immunology (232 citations), Molecular Biology (709 citations), Cancer Research (149 citations), Oncology (256 citations) and Toxicology (29 citations). Frederick O. Cope has collaborated with scholars based in United States, Sweden and India. Frequent co-authors include Licia Tomei, John P. Shapiro, R. K. Boutwell, John J. Wille, David R. Vera, Audrey Romano, Mariana M. Chaves, Sang‐Hun Lee, Andrea Paun and David L. Sacks. Their work appears in journals such as Journal of Clinical Oncology, Cancer Letters, Cellular and Molecular Life Sciences, Proceedings of the National Academy of Sciences and Molecular Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact